Aligos Therapeutics Stock (NASDAQ: ALGS) stock price, news, charts, stock research, profile.
You can purchase shares of Aligos Therapeutics (NASDAQ:ALGS) through any online brokerage.
Other companies in Aligos Therapeutics’s space includes: OncoCyte (NASDAQ:OCX), bluebird bio (NASDAQ:BLUE), Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR) and FibroGen (NASDAQ:FGEN).
Aligos Therapeutics has a consensus price target of $21.75.
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $19.4613 last updated February 21, 2025 at 6:04 PM EST.
There are no upcoming dividends for Aligos Therapeutics.
Aligos Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Aligos Therapeutics.
Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.